Jessica Robinson-Papp, MD, MS, professor of neurology at Icahn School of Medicine at Mount Sinai, discusses how neurologic symptoms in individuals with HIV can present in various places in the body while also possibly pointing to a neurologic condition.
Some neurologic symptoms in patients with HIV can be more obvious than others, says Jessica Robinson-Papp, MD, MS, professor of neurology at Icahn School of Medicine at Mount Sinai.
Transcript
What are some symptoms you look for in patients with HIV who you may suspect have a neurological complication of their HIV?
That can be really broad, and some of the symptoms, I think, are more overt than others. So, for example, in patients who have advanced immunosuppression and AIDS and we're worried about an infection in the brain, some of the symptoms might be things like headache or confusion [or] seizures. If it's an infection, you could have fever and other kinds of systemic signs of infection.
If it is a patient who is not particularly immunosuppressed, and has been doing well, often those neurologic complications are similar to somebody who didn't have HIV. In that case, you’re just basically starting with the symptoms that the patient complains of. Some of the things that I see a lot of are peripheral neuropathies. Those patients will sometimes complain of pain or numbness or tingling in the bottoms of their feet or coming up their legs. That can be a common symptom.
One of the other disorders that we see a lot of are HIV-associated neurocognitive disorders, which is abbreviated HAND, and those patients may report difficulty with different cognitive processes. So, maybe they're having trouble focusing like they used to, or handling their finances or their appointments or managing in their day-to-day life.
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AUA to Focus on Inclusive Care, Robotic Surgeries, and Future of Urology at 2024 Annual Meeting
May 1st 2024The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for providers, and discussions on cutting-edge treatments and global health initiatives.
Read More
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More